Clinical Studies Search

Protocol Summary


Protocol No.
PSHCI-14-053
Prinicipal Investigator
Gusani, Niraj
Phase
NA
Age Group
Adult
Scope
Local
Title
New Tumor Markers for Pancreatic Cancer in Blood
Objective
Primary Study Endpoints
The primary study endpoint is to measure CTC levels and MTF levels and compare these against known biomarkers expressed in pancreatic cancer.

Secondary Study Endpoints
The secondary study endpoints are to determine if novel markers are useful for the detection of CTCs and MTFs and whether levels of CTCs and MTFs correlate with therapeutic efficacy, as well as whether MTF marker expression patterns reflect response to therapeutic interventions.
Applicable Disease Sites
Pancreas
Status
Open
Participating Institutions
Hershey Medical Center